Thursday, Adial Pharmaceuticals Inc (NASDAQ:ADIL) said it has completed a pharmacokinetics (PK) study of AD04 for Alcohol Use ...

Confirmed relative bioavailability to the reference standard, dose proportional increases in pharmacokinetic exposure, and no food effectMarks ...

Adial Pharmaceuticals (ADIL) announced that it has completed a pharmacokinetics, PK, study of AD04, the Company’s lead investigational genetically targeted, serotonin-3 receptor antagonist, and ...

The pharmacokinetics of promethazine hydrochloride after administration of rectal suppositories at three dosage strengths and oral syrup were studied. The study had an open-label, randomized ...

Following oral administration of a drug, extent and speed of absorption is influenced by several processes. With respect to the formulation of the drug, this comprises: release of the active ...

BOSTON, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage biotechnology company ...

The findings of these research were presented at The Union World Conference on Lung Health in Bali, Indonesia. One of them is ...

Gilead Sciences, Inc. (Nasdaq: GILD) today presented the first in-depth look at full results from its pivotal Phase 3 PURPOSE ...

The rise of antibody therapeutics is transforming drug discovery, providing highly specific treatments for complex diseases ...

Tune Therapeutics Moves into Clinical Spotlight with TUNE-401: A First-in-Class Epigenetic Silencer for Hepatitis B ...

Sea's novel synthetic molecules act at the neurotransmitter glutamate pathway on two clinically validated targets in the central nervous system, "the CNS"Two potent, selective, pre-clinical stage ...

帕金森病（Parkinson disease，PD）是一种常见的中老年神经系统退行性疾病，因脑内多巴胺的减少、进而导致多巴胺与乙酰胆碱之间平衡被打破进而出现手抖、肢体僵硬、动作迟缓、姿势步态异常等运动症状及睡眠障碍、嗅觉障碍等非运动症状。